PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
65 hedge funds and large institutions have $191M invested in Poseida Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Holders
65
Holding in Top 10
–
Calls
$763K
Puts
$131K
Top Buyers
| 1 | +$1.35M | |
| 2 | +$721K | |
| 3 | +$590K | |
| 4 |
PFMU
Privium Fund Management (UK)
London,
United Kingdom
|
+$353K |
| 5 |
JPMorgan Chase & Co
New York
|
+$302K |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$3.78M | |
| 3 | -$993K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$861K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$804K |